Pemetrexed Baxter European Union - English - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5.1).pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).

ENDOXAN FOR INJECTION 1 gvial Singapore - English - HSA (Health Sciences Authority)

endoxan for injection 1 gvial

baxter healthcare (asia) pte ltd - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous - injection, powder, for solution - 1 g/vial - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous 1 g/vial

ENDOXAN FOR INJECTION 200 mgvial Singapore - English - HSA (Health Sciences Authority)

endoxan for injection 200 mgvial

baxter healthcare (asia) pte ltd - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous - injection, powder, for solution - 200 mg/vial - cyclophosphamide monohydrate eqv cyclophosphamide anhydrous 200 mg/vial

ENDOXAN FOR INJECTION 500 mgvial Singapore - English - HSA (Health Sciences Authority)

endoxan for injection 500 mgvial

baxter healthcare (asia) pte ltd - cyclophosphamide anhydrous - injection, powder, for solution - 500 mg/vial - cyclophosphamide anhydrous 500 mg/vial

HOLOXAN FOR INJECTION 1 g25 ml Singapore - English - HSA (Health Sciences Authority)

holoxan for injection 1 g25 ml

baxter healthcare (asia) pte ltd - ifosfamide - injection, powder, for solution - 1 g/25 ml - ifosfamide 1 g/25 ml

MITOXANTRONE BAXTER SOLUTION FOR INJECTION 20MG10ML (2MGML) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

mitoxantrone baxter solution for injection 20mg10ml (2mgml)

baxter healthcare (malaysia) sdn. bhd. - mitoxantrone hydrochloride -

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 30 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 20 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 20 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.